Source: BioPortfolio

PSG: Pharmaceutical Strategies Group to Share Specialty Drug Management Approaches at 21st Annual PBMI Conference

Fastrising drug costs especially for highpriced specialty drugs are grabbing much attention among health plans employers lawmakers and even presidential candidates. Pharmaceutical Strategies Group PSG the largest independent ...

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Est. Annual Revenue
Est. Employees
Dave Borden's photo - CEO of Pharmaceutical Strategies Group, LLC

CEO

Dave Borden

CEO Approval Rating

85/100

PSG is a provider of benefit consulting and data analytics services to the pharmaceutical sector. Read more